Caryl Schwartzbach

549 total citations
11 papers, 436 citations indexed

About

Caryl Schwartzbach is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Caryl Schwartzbach has authored 11 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Pharmacology. Recurrent topics in Caryl Schwartzbach's work include Mitochondrial Function and Pathology (4 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Caryl Schwartzbach is often cited by papers focused on Mitochondrial Function and Pathology (4 papers), Pain Mechanisms and Treatments (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Caryl Schwartzbach collaborates with scholars based in United States, United Kingdom and Netherlands. Caryl Schwartzbach's co-authors include Linda Spremulli, Robert A. Brown, Richard Grove, Debra Tompson, Douglas L. Arnold, Florian Then Bergh, Hua‐Xin Liao, Peadar G. Noone, Larry G. Johnson and Michael R. Knowles and has published in prestigious journals such as Journal of Biological Chemistry, Methods in enzymology on CD-ROM/Methods in enzymology and Anesthesia & Analgesia.

In The Last Decade

Caryl Schwartzbach

11 papers receiving 422 citations

Peers

Caryl Schwartzbach
Esther Steiner Switzerland
Ling Ouyang United States
Jamie Bergen United States
Amanda Courtright United States
J. Ridings Australia
William E. Grever United States
Caryl Schwartzbach
Citations per year, relative to Caryl Schwartzbach Caryl Schwartzbach (= 1×) peers Enrique Garcia-Valenzuela

Countries citing papers authored by Caryl Schwartzbach

Since Specialization
Citations

This map shows the geographic impact of Caryl Schwartzbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caryl Schwartzbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caryl Schwartzbach more than expected).

Fields of papers citing papers by Caryl Schwartzbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caryl Schwartzbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caryl Schwartzbach. The network helps show where Caryl Schwartzbach may publish in the future.

Co-authorship network of co-authors of Caryl Schwartzbach

This figure shows the co-authorship network connecting the top 25 collaborators of Caryl Schwartzbach. A scholar is included among the top collaborators of Caryl Schwartzbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caryl Schwartzbach. Caryl Schwartzbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Schwartzbach, Caryl, Richard Grove, Robert A. Brown, et al.. (2016). Lesion remyelinating activity of GSK239512 versus placebo in patients with relapsing-remitting multiple sclerosis: a randomised, single-blind, phase II study. Journal of Neurology. 264(2). 304–315. 86 indexed citations
3.
Harden, R. Norman, Roy Freeman, Michelle Rainka, et al.. (2013). A Phase 2a, Randomized, Crossover Trial of Gabapentin Enacarbil for the Treatment of Postherpetic Neuralgia in Gabapentin Inadequate Responders. Pain Medicine. 14(12). 1918–1932. 7 indexed citations
4.
Noone, Peadar G., Zhaoqing Zhou, Larry G. Johnson, et al.. (2000). Safety and Biological Efficacy of a Lipid–CFTR Complex for Gene Transfer in the Nasal Epithelium of Adult Patients with Cystic Fibrosis. Molecular Therapy. 1(1). 105–114. 99 indexed citations
6.
Schwartzbach, Caryl, Mary A. Farwell, Hua‐Xin Liao, & Linda Spremulli. (1996). [23] Bovine mitochondrial initiation and elongation factors. Methods in enzymology on CD-ROM/Methods in enzymology. 264. 248–261. 20 indexed citations
7.
Konstadt, Steven N., David L. Reich, Thomas E. Stanley, et al.. (1995). A Two-Center Comparison of the Cardiovascular Effects of Cisatracurium (Nimbex Trademmark) and Vecuronium in Patients with Coronary Artery Disease. Anesthesia & Analgesia. 81(5). 1010–1014. 22 indexed citations
8.
Konstadt, Steven N., David L. Reich, Thomas E. Stanley, et al.. (1995). A Two-Center Comparison of the Cardiovascular Effects of Cisatracurium (Nimbex Trademmark) and Vecuronium in Patients with Coronary Artery Disease. Anesthesia & Analgesia. 81(5). 1010–1014. 3 indexed citations
9.
Kumazawa, Yoshinori, Caryl Schwartzbach, Hua‐Xin Liao, et al.. (1991). Interactions of bovine mitochondrial phenylalanyl-tRNA with ribosomes and elongation factors from mitochondria and bacteria. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1090(2). 167–172. 36 indexed citations
10.
Schwartzbach, Caryl & Linda Spremulli. (1991). Interaction of animal mitochondrial EF-Tu.EF-Ts with aminoacyl-tRNA, guanine nucleotides, and ribosomes.. Journal of Biological Chemistry. 266(25). 16324–16330. 31 indexed citations
11.
Schwartzbach, Caryl & Linda Spremulli. (1989). Bovine mitochondrial protein synthesis elongation factors. Journal of Biological Chemistry. 264(32). 19125–19131. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026